Moreover, Wang et al. reported that resveratrol, as an activator of SIRT1, plays an anti-tumor role in NSCLC by inhibiting Akt/mTOR and activating p38-MAPK pathway (Wang J. et al., 2018). The gene discussed is MTOR; the disease is neoplasm.